Credit Suisse’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-111,102
| Closed | -$2.11M | – | 3590 |
|
|
2019
Q1 | $2.11M | Buy |
+111,102
| New | +$2.11M | ﹤0.01% | 1859 |
|
|
2017
Q1 | – | Sell |
-12,200
| Closed | -$60K | – | 3815 |
|
|
2016
Q4 | $60K | Sell |
12,200
-387
| -3% | -$1.9K | ﹤0.01% | 3641 |
|
|
2016
Q3 | $62K | Sell |
12,587
-2,298
| -15% | -$11.3K | ﹤0.01% | 3650 |
|
|
2016
Q2 | $76K | Sell |
14,885
-8,398
| -36% | -$42.9K | ﹤0.01% | 3791 |
|
|
2016
Q1 | $133K | Sell |
23,283
-9,215
| -28% | -$52.6K | ﹤0.01% | 3478 |
|
|
2015
Q4 | $338K | Buy |
32,498
+6,311
| +24% | +$65.6K | ﹤0.01% | 3403 |
|
|
2015
Q3 | $483K | Sell |
26,187
-19,901
| -43% | -$367K | ﹤0.01% | 3220 |
|
|
2015
Q2 | $897K | Buy |
46,088
+16,555
| +56% | +$322K | ﹤0.01% | 3030 |
|
|
2015
Q1 | $520K | Buy |
29,533
+10,128
| +52% | +$178K | ﹤0.01% | 3262 |
|
|
2014
Q4 | $310K | Sell |
19,405
-353
| -2% | -$5.64K | ﹤0.01% | 3669 |
|
|
2014
Q3 | $249K | Buy |
19,758
+2,245
| +13% | +$28.3K | ﹤0.01% | 3636 |
|
|
2014
Q2 | $274K | Sell |
17,513
-41,934
| -71% | -$656K | ﹤0.01% | 3749 |
|
|
2014
Q1 | $781K | Buy |
59,447
+15,905
| +37% | +$209K | ﹤0.01% | 2994 |
|
|
2013
Q4 | $700K | Sell |
43,542
-11,530
| -21% | -$185K | ﹤0.01% | 3138 |
|
|
2013
Q3 | $917K | Buy |
55,072
+8,637
| +19% | +$144K | ﹤0.01% | 2647 |
|
|
2013
Q2 | $468K | Buy |
+46,435
| New | +$468K | ﹤0.01% | 2968 |
|